acne: become more common

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents disease
Weight: 0.64
, condition
Weight: 0.63
, symptom
Weight: 0.59
, problem
Weight: 0.57
, brand
Weight: 0.57
Siblings lyme disease
Weight: 0.37
, psoriasis
Weight: 0.36
, pelvic inflammatory disease
Weight: 0.36
, genital herpes
Weight: 0.35
, allergy
Weight: 0.35

Related properties

Property Similarity
become more common 1.00
become common 0.97
is more common 0.95
is more common nowadays 0.90
is common 0.89
is common nowadays 0.87
is more prevalent now 0.83
is common problem 0.81
is more prevalent 0.81
be more prevalent than else 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.10
Rule weight: 0.13
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.78
¬ Remarkable(lyme disease, become more common)
0.10
Rule weight: 0.13
Evidence weight: 0.77
Similarity weight: 0.95
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.77
¬ Remarkable(allergy, is more common)
0.09
Rule weight: 0.13
Evidence weight: 0.72
Similarity weight: 0.97
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.92
¬ Remarkable(lyme disease, become common)
0.09
Rule weight: 0.13
Evidence weight: 0.77
Similarity weight: 0.89
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.77
¬ Remarkable(psoriasis, is common)
0.09
Rule weight: 0.13
Evidence weight: 0.74
Similarity weight: 0.89
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.86
¬ Remarkable(allergy, is common)
0.09
Rule weight: 0.13
Evidence weight: 0.80
Similarity weight: 0.81
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.66
¬ Remarkable(allergy, is more prevalent)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.97
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.92
Remarkable(lyme disease, become common)
Evidence: 0.43
¬ Plausible(lyme disease, become common)
0.55
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.78
Remarkable(lyme disease, become more common)
Evidence: 0.73
¬ Plausible(lyme disease, become more common)
0.52
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.95
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.77
Remarkable(allergy, is more common)
Evidence: 0.77
¬ Plausible(allergy, is more common)
0.51
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.89
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.86
Remarkable(allergy, is common)
Evidence: 0.61
¬ Plausible(allergy, is common)
0.48
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.89
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.77
Remarkable(psoriasis, is common)
Evidence: 0.77
¬ Plausible(psoriasis, is common)
0.42
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 0.81
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.66
Remarkable(allergy, is more prevalent)
Evidence: 0.76
¬ Plausible(allergy, is more prevalent)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.35
¬ Salient(acne, become more common)

Similarity expansion

0.58
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.83
Evidence: 0.66
Typical(acne, become more common)
Evidence: 0.51
¬ Typical(acne, is more prevalent now)
0.54
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.83
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.44
¬ Plausible(acne, is more prevalent now)
0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.83
Evidence: 0.35
Salient(acne, become more common)
Evidence: 0.42
¬ Salient(acne, is more prevalent now)
0.46
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.83
Evidence: 0.30
Remarkable(acne, become more common)
Evidence: 0.50
¬ Remarkable(acne, is more prevalent now)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.35
Salient(acne, become more common)
Evidence: 0.66
¬ Typical(acne, become more common)
Evidence: 0.30
¬ Remarkable(acne, become more common)

Typical implies Plausible

0.31
Rule weight: 0.48
Evidence weight: 0.65
Similarity weight: 1.00
Evidence: 0.47
Plausible(acne, become more common)
Evidence: 0.66
¬ Typical(acne, become more common)

Typicality and Rermarkability incompatibility between siblings

0.12
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 0.97
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.25
¬ Typical(lyme disease, become common)
0.11
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.71
¬ Typical(lyme disease, become more common)
0.10
Rule weight: 0.14
Evidence weight: 0.84
Similarity weight: 0.89
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.52
¬ Typical(allergy, is common)
0.10
Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 0.95
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.77
¬ Typical(allergy, is more common)
0.09
Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 0.89
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.75
¬ Typical(psoriasis, is common)
0.08
Rule weight: 0.14
Evidence weight: 0.76
Similarity weight: 0.81
Evidence: 0.30
¬ Remarkable(acne, become more common)
Evidence: 0.81
¬ Typical(allergy, is more prevalent)